ORMP

$3.64+0.14 (+4.00%)

Market OpenAs of Mar 17, 6:40 PM UTC

Oramed Pharmaceuticals Inc.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$3.64
Potential Upside
529%
Whystock Fair Value$22.90
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryBiotechnology

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical t...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$145.05M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
3.64
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.28
Div Yield
Strong income play. Yield provides a meaningful total return floor.
714.00%
ROIC
Elite ROE. Management converts capital into profit efficiently.
24.48%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
22.08

Recent News

Motley Fool
Feb 3, 2026

CarMax Stock Down 47% This Past Year, But One Fund Is Betting $6 Million on a Turnaround

CarMax runs a nationwide network of used car stores and digital channels, offering multi-channel sales and financing to U.S. consumers.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Motley Fool
Feb 3, 2026

Alumis Stock Has Rallied 250% This Past Year. One Fund Sold Its $5 Million Stake Last Quarter.

This clinical-stage biotech develops therapies targeting autoimmune and neuroinflammatory diseases with a focus on TYK2 inhibition.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Simply Wall St.
Jan 14, 2026

3 Promising Penny Stocks With Market Caps Under $200M

As the S&P 500 and Dow Jones Industrial Average reach new highs, investors continue to navigate a landscape marked by both opportunities and challenges. For those looking to invest in smaller or newer companies, penny stocks — despite the name's vintage feel — can still offer surprising value. With solid financial foundations, these stocks have the potential to outperform while offering greater stability.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Dec 16, 2025

Oramed Pharmaceuticals And 2 Other Promising Penny Stocks To Watch

As the U.S. stock market navigates a period of volatility, with major indexes closing lower amid AI bubble concerns and upcoming economic data releases, investors are exploring diverse opportunities. Penny stocks, often associated with smaller or newer companies, offer a unique investment avenue that combines affordability with potential growth. Despite being considered an outdated term, these stocks remain relevant by providing access to companies that may have strong financials and growth...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Nov 21, 2025

There Are Some Holes In Oramed Pharmaceuticals' (NASDAQ:ORMP) Solid Earnings Release

Investors appear disappointed with Oramed Pharmaceuticals Inc.'s ( NASDAQ:ORMP ) recent earnings, despite the decent...

BEARISH
Negative press. News cycle fixated on risk factors or misses.